Patricia E. Ganey

5.9k total citations
128 papers, 4.5k citations indexed

About

Patricia E. Ganey is a scholar working on Pharmacology, Immunology and Molecular Biology. According to data from OpenAlex, Patricia E. Ganey has authored 128 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Pharmacology, 40 papers in Immunology and 36 papers in Molecular Biology. Recurrent topics in Patricia E. Ganey's work include Drug-Induced Hepatotoxicity and Protection (64 papers), Immune Response and Inflammation (25 papers) and Drug Transport and Resistance Mechanisms (21 papers). Patricia E. Ganey is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (64 papers), Immune Response and Inflammation (25 papers) and Drug Transport and Resistance Mechanisms (21 papers). Patricia E. Ganey collaborates with scholars based in United States, Czechia and France. Patricia E. Ganey's co-authors include Robert A. Roth, James P. Luyendyk, Jane F. Maddox, Patrick J. Shaw, Patricia K. Tithof, Alan Brown, John P. Buchweitz, Xiaomin Deng, Lisa M. Kamendulis and Ju Chen and has published in prestigious journals such as Blood, The Journal of Immunology and Circulation Research.

In The Last Decade

Patricia E. Ganey

128 papers receiving 4.4k citations

Peers

Patricia E. Ganey
Patricia E. Ganey
Citations per year, relative to Patricia E. Ganey Patricia E. Ganey (= 1×) peers A. Guillouzo

Countries citing papers authored by Patricia E. Ganey

Since Specialization
Citations

This map shows the geographic impact of Patricia E. Ganey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia E. Ganey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia E. Ganey more than expected).

Fields of papers citing papers by Patricia E. Ganey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia E. Ganey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia E. Ganey. The network helps show where Patricia E. Ganey may publish in the future.

Co-authorship network of co-authors of Patricia E. Ganey

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia E. Ganey. A scholar is included among the top collaborators of Patricia E. Ganey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia E. Ganey. Patricia E. Ganey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olivero‐Verbel, Jesús, Jack R. Harkema, Robert A. Roth, & Patricia E. Ganey. (2021). Fenofibrate, a peroxisome proliferator-activated receptor-alpha agonist, blocks steatosis and alters the inflammatory response in a mouse model of inflammation-dioxin interaction. Chemico-Biological Interactions. 345. 109521–109521. 3 indexed citations
3.
Poulsen, Kyle L., Jesús Olivero‐Verbel, Kevin M. Beggs, Patricia E. Ganey, & Robert A. Roth. (2014). Trovafloxacin Enhances Lipopolysaccharide-Stimulated Production of Tumor Necrosis Factor-α by Macrophages: Role of the DNA Damage Response. Journal of Pharmacology and Experimental Therapeutics. 350(1). 164–170. 25 indexed citations
4.
Beggs, Kevin M., Aaron Fullerton, Kazuhisa Miyakawa, Patricia E. Ganey, & Robert A. Roth. (2013). Molecular Mechanisms of Hepatocellular Apoptosis Induced by Trovafloxacin-Tumor Necrosis Factor-alpha Interaction. Toxicological Sciences. 137(1). 91–101. 28 indexed citations
5.
Fullerton, Aaron, et al.. (2011). Natural Killer Cells Mediate Severe Liver Injury in a Murine Model of Halothane Hepatitis. Toxicological Sciences. 120(2). 507–518. 27 indexed citations
6.
Shaw, Patrick J., Patricia E. Ganey, & Robert A. Roth. (2009). Trovafloxacin Enhances the Inflammatory Response to a Gram-Negative or a Gram-Positive Bacterial Stimulus, Resulting in Neutrophil-Dependent Liver Injury in Mice. Journal of Pharmacology and Experimental Therapeutics. 330(1). 72–78. 31 indexed citations
7.
Deng, Xiaomin, James P. Luyendyk, Patricia E. Ganey, & Robert A. Roth. (2009). Inflammatory Stress and Idiosyncratic Hepatotoxicity: Hints from Animal Models. Pharmacological Reviews. 61(3). 262–282. 101 indexed citations
8.
Deng, Xiaomin, Jingtao Lu, Lois D. Lehman‐McKeeman, et al.. (2008). p38 Mitogen-Activated Protein Kinase-Dependent Tumor Necrosis Factor-α-Converting Enzyme Is Important for Liver Injury in Hepatotoxic Interaction between Lipopolysaccharide and Ranitidine. Journal of Pharmacology and Experimental Therapeutics. 326(1). 144–152. 14 indexed citations
9.
Waring, Jeffrey F., Michael J. Liguori, James P. Luyendyk, et al.. (2006). Microarray Analysis of Lipopolysaccharide Potentiation of Trovafloxacin-Induced Liver Injury in Rats Suggests a Role for Proinflammatory Chemokines and Neutrophils. Journal of Pharmacology and Experimental Therapeutics. 316(3). 1080–1087. 94 indexed citations
10.
Luyendyk, James P., Lois D. Lehman‐McKeeman, David M. Nelson, et al.. (2006). Unique Gene Expression and Hepatocellular Injury in the Lipopolysaccharide-Ranitidine Drug Idiosyncrasy Rat Model: Comparison with Famotidine. Toxicological Sciences. 90(2). 569–585. 9 indexed citations
11.
Luyendyk, James P., Lois D. Lehman‐McKeeman, David M. Nelson, et al.. (2006). Coagulation-Dependent Gene Expression and Liver Injury in Rats Given Lipopolysaccharide with Ranitidine but Not with Famotidine. Journal of Pharmacology and Experimental Therapeutics. 317(2). 635–643. 20 indexed citations
12.
Yee, Steven B., Jack R. Harkema, Patricia E. Ganey, & R A Roth. (2003). The Coagulation System Contributes to Synergistic Liver Injury from Exposure to Monocrotaline and Bacterial Lipopolysaccharide. Toxicological Sciences. 74(2). 457–469. 18 indexed citations
13.
Yee, Steven B., Bryan L. Copple, Patricia E. Ganey, & Robert A. Roth. (2002). THE TEMPORAL RELATIONSHIP BETWEEN BACTERIAL LIPOPOLYSACCHARIDE AND MONOCROTALINE EXPOSURES INFLUENCES TOXICITY: SHIFT IN RESPONSE FROM HEPATOTOXICITY TO NITRIC OXIDE-DEPENDENT LETHALITY. Journal of Toxicology and Environmental Health. 65(14). 961–976. 5 indexed citations
14.
Ganey, Patricia E., et al.. (2001). Bacterial Lipopolysaccharide Enhances Aflatoxin B1 Hepatotoxicity in Rats by A Mechanism That Depends on Tumor Necrosis Factor α. Hepatology. 33(1). 66–73. 69 indexed citations
15.
Olivero, Jesús & Patricia E. Ganey. (2000). Role of Protein Phosphorylation in Activation of Phospholipase A2 by the Polychlorinated Biphenyl Mixture Aroclor 1242. Toxicology and Applied Pharmacology. 163(1). 9–16. 29 indexed citations
16.
Molnar, Robert G., Ping Wang, Alfred Ayala, et al.. (1997). The Role of Neutrophils in Producing Hepatocellular Dysfunction during the Hyperdynamic Stage of Sepsis in Rats. Journal of Surgical Research. 73(2). 117–122. 47 indexed citations
17.
Pearson, Julia M., Alan Brown, A. Eric Schultze, Patricia E. Ganey, & Robert A. Roth. (1996). GADOLINIUM CHLORIDE TREATMENT ATTENUATES HEPATIC PLATELET ACCUMULATION AFTER LIPOPOLYSACCHARIDE ADMINISTRATION. Shock. 5(6). 408–415. 19 indexed citations
19.
Ganey, Patricia E.. (1995). Depletion of neutrophils and modulation of Kupffer cell function in allyl alcohol-induced hepatotoxicity. Toxicology. 99(1-2). 99–106. 16 indexed citations
20.
Ganey, Patricia E. & Robert A. Roth. (1987). Elevated serum copper concentration in monocrotaline pyrrole treated rats with pulmonary hypertension. Biochemical Pharmacology. 36(20). 3535–3537. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026